Construction and Evaluation of an Antibody Phage Display Library Targeting Heparan Sulfate

Construction and Evaluation of an Antibody Phage Display Library Targeting Heparan Sulfate
Heparan sulfate (HS) is a linear polysaccharide with excessive structural range. Totally different HS epitopes have been detected and localized utilizing single chain variable fragment (scFv) antibodies from a ‘single pot’ phage show library containing a randomized complementarity figuring out area of the heavy chain (CDR3).
On this examine, we created a brand new library containing anti-HS scFvs that every one harbor a dp-38 heavy chain section the place the CDR3 area was engineered to include the XBBXBX heparin binding consensus website (X = any amino acid, B = R, Okay or H).
The library contained ~1.73 × 106 distinctive antibodies and was biopanned in opposition to HS from a number of sources. The chosen antibodies have been sequenced and chemically/immunohistologically characterised. Numerous 67 anti-HS scFv antibodies have been chosen, of which 31 contained a XBBXBX CDR3 sequence.
There was a transparent choice for glycine on the first and proline on the fourth place of the CDR3. The sequence GZZP(R/Okay)X (Z = R, Okay or H, however can also include N, S, or Q) was unusually overrepresented. Chosen antibodies reacted with HS/heparin, however not with different glycosaminoglycans.
Antibodies reacted differentially with respect to N-, 2-O, or 6-O-desulfated heparin preparations, and confirmed distinct topologies of HS epitopes in rat kidney sections. The library could also be instrumental within the choice of a big pool of HS epitope-specific antibodies, and – since all antibodies differ solely of their 6 amino acid CDR area – could also be a instrument for a rational design of antibodies recognizing particular HS sulfation patterns.

Heparan sulfate proteoglycans (HSPGs) and chondroitin sulfate proteoglycans (CSPGs) perform as endocytic receptors for an internalizing anti-nucleic acid antibody.

A subset of monoclonal anti-DNA autoantibodies enters quite a lot of residing cells. Right here, we aimed to determine the endocytic receptors acknowledged by an internalizing anti-nucleic acid autoantibody, the 3D8 single-chain variable fragment (scFv).
We discovered that cell floor binding and internalization of 3D8 scFv have been inhibited markedly in soluble heparan sulfate (HS)/chondroitin sulfate (CS)-deficient or -removed cells and within the presence of soluble HS and CS. 3D8 scFv colocalized intracellularly with both HS proteoglycans (HSPGs) or CSPGs in HeLa cells.
3D8 scFv was co-endocytosed and co-precipitated with consultant particular person HSPG and CSPG molecules: syndecan-2 (a transmembrane HSPG), glypican-3 (a glycosylphosphatidylinositol (GPI)-anchored HSPG); CD44 (a transmembrane CSPG); and brevican (a GPI-anchored CSPG).
Collected knowledge point out that 3D8 scFv binds to the negatively charged sugar chains of each HSPGs and CSPGs and is then internalized together with these molecules, no matter how these proteoglycans are related to the cell membrane.
That is the primary examine to indicate that anti-DNA antibodies enter cells through each HSPGs and CSPGs concurrently. The information might support understanding of endocytic receptors that bind anti-DNA autoantibodies. The examine additionally gives perception into potential cell membrane targets for macromolecular supply.

Anti-heparan sulfate antibody and useful lack of glomerular heparan sulfate proteoglycans in lupus nephritis.

Background The aim of this examine was to guage the options of heparan sulfate proteoglycans (HSPGs) as agrins of the glomerular basement membrane (GBM) and circulating anti-heparan sulfate (HS) antibodies in lupus nephritis, evaluating titers among the many following teams: lupus nephritis (LN), non-renal lupus, non-lupus nephritis, and wholesome controls.
Strategies The stage of nephritis was decided based mostly on the kidney biopsy. Alcian blue staining and immunohistochemical (IHC) staining for agrin have been carried out for histological analysis of GBM HSPGs in regular glomeruli, non-lupus membranous glomerulonephritis (MGN), and lupus MGN.
The outcomes have been used for measurement of the serum anti-HS antibody titers utilizing an enzyme-linked immunosorbent assay (ELISA) within the following teams: 38 wholesome controls, 38 non-lupus nephritis, 37 non-renal lupus, and 38 LN. Outcomes Glomerulus HSPGs have been stained bluish-green alongside the GBM with Alcian blue.
Nevertheless, IHC staining in opposition to agrin was virtually utterly destructive within the lupus MGN group in contrast with the traditional and non-lupus MGN teams, which confirmed brown staining of GBM. The next stage of anti-HS IgG was detected in LN in contrast with different teams, respectively. Greater titers have been related to the presence of SLE and nephritis.
The next diploma of proteinuria normalized to glomerular filtration fee (eGFR) was noticed in affiliation with increased anti-HS antibody titers in LN. Conclusion This examine demonstrated a useful lack of GBM HSPGs and better ranges of circulating anti-HS antibodies as a attribute characteristic of lupus nephritis, suggesting their involvement within the pathogenesis of lupus nephritis and proteinuria.

Isolation of Antibodies to Heparan Sulfate on Glypicans by Phage Show.

Heparan sulfate (HS) performs an essential position in improvement and illness. It interacts with many progress components, chemokines, and different ligands recognized to be essential for cell progress, motility, and differentiation.
Nevertheless, isolating an antibody to HS in mice, rabbits, or people is troublesome because of the poor immunogenicity of HS. Phage show is a serious antibody engineering know-how that permits the choice of antibodies for poorly immunogenic or extremely conserved antigens.
This protocol incorporates detailed procedures for HS antigen preparation and isolation of a phage displayed human single-chain Fv (HS20) that binds HS on glypican-3 (GPC3), and evaluation of the chosen phage antibody. It’s conceivable that the procedures described on this protocol could also be relevant to the isolation of antibodies for quite a lot of HS molecules.
Construction and Evaluation of an Antibody Phage Display Library Targeting Heparan Sulfate

The technology and characterisation of neutralising antibodies in opposition to the Theiler’s murine encephalomyelitis virus (TMEV) GDVII capsid reveals the potential binding website of the host cell co-receptor, heparan sulfate.

The early phases of picornavirus capsid meeting and the host components concerned are poorly understood. Because the localisation of viral proteins in contaminated cells can present info on their perform, antibodies in opposition to purified Theiler’s murine encephalomyelitis virus (TMEV) GDVII capsids have been generated by immunisation of rabbits.
The resultant anti-TMEV capsid antibodies recognised a C-terminal area of VP1 however not VP2 or VP3 by Western evaluation. Examination of the websites of TMEV capsid meeting by oblique immunofluorescence and confocal microscopy confirmed that at 5h submit an infection, capsid sign was diffusely cytoplasmic with robust perinuclear staining and moved into giant punctate constructions from 6 to 8h submit an infection.
A plaque discount neutralisation assay confirmed that the anti-TMEV capsid antibodies however not anti-VP1 antibodies might neutralise viral an infection in vitro. The VP1 C-terminal residues recognised by the anti-TMEV capsid antibodies have been mapped to a loop on the capsid floor close to to the putative receptor binding pocket.
In silico docking experiments confirmed that the recognized TMEV co-receptor, heparan sulfate, interacts with residues of VP1 within the putative receptor binding pocket, residues of VP3 within the adjoining pit and residues of the adjoining VP1 C-terminal loop which is recognised by the anti-TMEV capsid antibodies.

Heparan Sulfate

T19355-1mg 1mg Ask for price
Description: Heparan Sulfate

Heparan Sulfate

T19355-50mg 50mg Ask for price
Description: Heparan Sulfate

Heparan Sulfate

T19355-5mg 5mg Ask for price
Description: Heparan Sulfate

Heparan Sulfate

HY-101916 25mg
EUR 2373.6

N-Sulfated Heparan Sulfate Antibody (Biotin)

abx140577-100g 100 µg
EUR 350

OASA00791-100UG - HEPARIN/HEPARAN SULFATE Antibody

OASA00791-100UG 0.1mg
EUR 859

Heparan Sulfate Proteoglycan (HSPG) Antibody

20-abx172768
  • Ask for price
  • Ask for price
  • 1 mg
  • 200 ug

Heparan Sulfate Proteoglycan (HSPG) Antibody

20-abx176805
  • Ask for price
  • Ask for price
  • 1 mg
  • 200 ug

Heparan Sulfate Proteoglycan (HSPG) Antibody

20-abx102870
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Heparan Sulfate Proteoglycan 2 (HSPG2) Antibody

20-abx172769
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Heparan Sulfate Proteoglycan 2 (HSPG2) Antibody

20-abx176806
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Heparan Sulfate Proteoglycan 2 (HSPG2) Antibody

20-abx176807
  • Ask for price
  • Ask for price
  • 1 mg
  • 200 ug

Heparan Sulfate Proteoglycan 2 (HSPG2) Antibody

20-abx212992
  • Ask for price
  • Ask for price
  • 100 ul
  • 50 ul

Heparan Sulfate Proteoglycan 2 (HSPG2) Antibody

20-abx213095
  • Ask for price
  • Ask for price
  • 100 ul
  • 50 ul

Heparan Sulfate Proteoglycan 2 (HSPG2) Antibody

20-abx112974
  • Ask for price
  • Ask for price
  • 150 ul
  • 50 ul

Heparan Sulfate Proteoglycan 2 (HSPG2) Antibody

20-abx103270
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Heparan Sulfate Proteoglycan 2 (HSPG2) Antibody

abx112974-100l 100 µl
EUR 612.5

Heparan Sulfate Proteoglycan 2 (HSPG2) Antibody

abx103270-100g 100 µg
EUR 750

Heparan Sulfate Proteoglycan 2 (HSPG2) Antibody

abx103270-20g 20 µg
EUR 275

Heparan Sulfate Proteoglycan 2 (HSPG2) Antibody

abx103270-50g 50 µg
EUR 337.5

Heparan Sulfate Proteoglycan 2 (HSPG2) Antibody

abx240009-100l 100 µl Ask for price

Heparan Sulfate Proteoglycan 2 (HSPG2) Antibody

abx240009-50l 50 µl
EUR 350

Heparan Sulfate Proteoglycan 2 (HSPG2) Antibody

abx176806-1096tests 10 × 96 tests
EUR 775

Heparan Sulfate Proteoglycan 2 (HSPG2) Antibody

abx176806-596tests 5 × 96 tests
EUR 350

Heparan Sulfate Proteoglycan 2 (HSPG2) Antibody

abx176806-96tests 96 tests
EUR 275

Heparan Sulfate Proteoglycan 2 (HSPG2) Antibody

abx212992-100l 100 µl
EUR 350

Heparan Sulfate Proteoglycan 2 (HSPG2) Antibody

abx212992-50l 50 µl
EUR 250

Heparan Sulfate Proteoglycan 2 (HSPG2) Antibody

abx213095-100l 100 µl
EUR 350

Heparan Sulfate Proteoglycan 2 (HSPG2) Antibody

abx213095-50l 50 µl
EUR 250

Heparan Sulfate Proteoglycan 2 (HSPG2) Antibody

abx172769-1ml 1 ml
EUR 275

Heparan Sulfate Proteoglycan (HSPG) Antibody (FITC)

20-abx273784
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Heparan Sulfate Proteoglycan (HSPG) Antibody (Biotin)

20-abx272006
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Mouse Anti Heparin/Heparan Sulfate Monoclonal Antibody

DMABT-54795MH 0.1 mg
EUR 1263.6

Heparan Sulfate Proteoglycan (HSPG) Polyclonal Antibody

CAU27639-100ul 100ul
EUR 212.2

Heparan Sulfate Proteoglycan (HSPG) Polyclonal Antibody

CAU27639-200ul 200ul
EUR 265.4

Heparan Sulfate ELISA Kit

ECP7878 96 Tests
EUR 713

Heparan Sulfate Proteoglycan 2 (HSPG2) Antibody (Biotin)

20-abx272294
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Heparan Sulfate Proteoglycan 2 (HSPG2) Antibody (Biotin)

abx272294-1ml 1 ml
EUR 825

Heparan Sulfate Proteoglycan 2 (HSPG2) Antibody (Biotin)

abx272294-200l 200 µl
EUR 362.5
These findings recommend that the anti-TMEV capsid antibodies neutralise virus an infection by stopping heparan sulfate from binding to the capsid. The antibodies produced on this examine are an essential instrument for additional investigating virus-host cell interactions important to picornavirus meeting.

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Post

A MET-agonistic antibody accelerates cirrhotic liver regeneration and improves mouse survival following partial hepatectomy

A MET-agonistic antibody accelerates cirrhotic liver regeneration and improves mouse survival following partial hepatectomyA MET-agonistic antibody accelerates cirrhotic liver regeneration and improves mouse survival following partial hepatectomy

Small-for-size syndrome is a standard complication following partial liver transplantation and prolonged hepatectomy. Small-for-size syndrome is characterised by post-operative liver dysfunction attributable to inadequate regenerative capability and portal hyper-perfusion, and